N. Oikawa

发表

Design, synthesis and antifungal activity of a novel water soluble prodrug of antifungal triazole.

M. Sakaitani, Y. Isshiki, N. Shimma, 2003, Bioorganic & medicinal chemistry letters.

Quantitative Structure-Activity Studies of Insect Growth Regulators: X. Substituent Effects on Larvicidal Activity of 1-tert-Butyl-1-(2-chlorobenzoyl)-2-(substituted benzoyl)hydrazines against Chilo suppressalis and Design Synthesis of Potent Derivatives

T. Fujita, Y. Nakagawa, K. Nishimura, 1994 .

Enhancement of N-acetylglucosamine incorporation into the cultured integument of Chilo suppressalis by molting hormone and dibenzoylhydrazine insecticides

T. Fujita, Y. Nakagawa, N. Kurihara, 1993 .

Quantitative structure—activity studies of insect growth regulators. XI. Stimulation and inhibition of N‐acetylglucosamine incorporation in a cultured integument system by substituted N‐tert‐butyl‐N,N′‐dibenzoylhydrazines

T. Fujita, Y. Nakagawa, N. Kurihara, 1995 .

Three-Dimensional Quantitative Structure—Activity Analysis of Steroidal and Dibenzoylhydrazine-Type Ecdysone Agonists

T. Fujita, M. Akamatsu, Y. Nakagawa, 1995 .

High-throughput screening of ecdysone agonists using a reporter gene assay followed by 3-D QSAR analysis of the molting hormonal activity.

Toshiyuki Harada, Yoshiaki Nakagawa, Craig E Wheelock, 2006, Bioorganic & medicinal chemistry.

Analysis and prediction of hydrophobicity parameters of substituted acetanilides, benzamides and related aromatic compounds

Toshio Fujita, Yoshiaki Nakagawa, T. Fujita, 1992 .

Discovery of CH7057288 as an Orally Bioavailable, Selective, and Potent pan-TRK Inhibitor.

Hiroki Nishii, Fumio Watanabe, M. Matsushita, 2022, Journal of medicinal chemistry.

Design and synthesis of the tumor-activated prodrug of dihydropyrimidine dehydrogenase (DPD) inhibitor, RO0094889 for combination therapy with capecitabine.

H. Ishitsuka, I. Horii, N. Shimma, 2003, Bioorganic & medicinal chemistry letters.

Quantitative structure-activity relationships of benzoylphenylurea larvicides

T. Fujita, H. Iwamura, Y. Nakagawa, 1991 .

CH5424802, a selective ALK inhibitor capable of blocking the resistant gatekeeper mutant.

Hiroshi Sakamoto, H. Sakamoto, T. Fukami, 2011, Cancer cell.

Quantitative structure-activity analysis of larvicidal 1-(substituted benzoyl)-2-benzoyl-1-tert-butylhydrazines against Chilo suppressalis

T. Fujita, Y. Nakagawa, K. Nishimura, 1994 .

MITF suppression improves the sensitivity of melanoma cells to a BRAF inhibitor.

H. Sakamoto, Takakazu Mizuno, S. Aida, 2017, Cancer letters.

Activity of ecdysone analogs in enhancing N-acetylglucosamine incorporation into the cultured integument of Chilo suppressalis

Y. Nakagawa, N. Kurihara, K. Nishimura, 1995, Steroids.

Anaplastic Lymphoma Kinase Inhibitors for the Treatment of ALK-Positive Cancers

Takuo Tsukuda, N. Oikawa, Kazutomo Kinoshita, 2012 .

Discovery of novel tetracyclic compounds as anaplastic lymphoma kinase inhibitors.

H. Sakamoto, Shota Tanaka, K. Morikami, 2011, Bioorganic & medicinal chemistry letters.

Design and synthesis of a highly selective, orally active and potent anaplastic lymphoma kinase inhibitor (CH5424802).

H. Sakamoto, Takamitsu Kobayashi, Noriyuki Furuichi, 2012, Bioorganic & medicinal chemistry.

Selective TRK Inhibitor CH7057288 against TRK Fusion-Driven Cancer

Miyuki Yoshida, Kenji Takanashi, A. Higashida, 2018, Molecular Cancer Therapeutics.

9-substituted 6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazoles as highly selective and potent anaplastic lymphoma kinase inhibitors.

H. Sakamoto, Takamitsu Kobayashi, Noriyuki Furuichi, 2011, Journal of medicinal chemistry.

Identification of a Novel Vascular Endothelial Growth Factor Receptor 2 Inhibitor and Its Effect for Choroidal Neovascularization In Vivo

R. Obata, Y. Inoue, Y. Tamaki, 2008, Current eye research.

Quantitative structure-activity relationships and designed synthesis of larvicidal N,N′-dibenzoyl-N-tert-butylhydrazines against Chilo suppressalis

T. Fujita, Y. Nakagawa, K. Nishimura, 1995 .